George W Padberg
Overview
Explore the profile of George W Padberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
2670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vincenten S, van Doorn J, Teeselink S, Rasing N, Padberg G, Voermans N, et al.
Muscle Nerve
. 2024 Sep;
70(5):1062-1071.
PMID: 39297366
Introduction/aims: One of the most distinct clinical features of facioscapulohumeral muscular dystrophy (FSHD) is facial weakness. It leads to diminished facial expression and functional impairments. Despite its clinical relevance, little...
2.
3.
Tenney A, Di Gioia S, Webb B, Chan W, de Boer E, Garnai S, et al.
Nat Genet
. 2023 Jun;
55(7):1149-1163.
PMID: 37386251
Hereditary congenital facial paresis type 1 (HCFP1) is an autosomal dominant disorder of absent or limited facial movement that maps to chromosome 3q21-q22 and is hypothesized to result from facial...
4.
Goselink R, Schreur V, van Kernebeek C, Padberg G, van der Maarel S, van Engelen B, et al.
Brain Commun
. 2020 Sep;
1(1):fcz023.
PMID: 32954265
Ophthalmological abnormalities in facioscapulohumeral dystrophy may lead to treatable vision loss, facilitate diagnostics, could help unravelling the pathophysiology and serve as biomarkers. In this study, we provide a detailed description...
5.
Kinoshita J, Magdinier F, Padberg G
Neuromuscul Disord
. 2019 Oct;
29(10):811-817.
PMID: 31604652
No abstract available.
6.
Goselink R, Mul K, van Kernebeek C, Lemmers R, van der Maarel S, Schreuder T, et al.
Neurology
. 2018 Dec;
92(4):e378-e385.
PMID: 30568007
Objective: To assess the relation between age at onset and disease severity in facioscapulohumeral muscular dystrophy (FSHD). Methods: In this prospective cross-sectional study, we matched adult patients with FSHD with...
7.
Abel E, Cup E, Lanser A, Leclercq W, Raaphorst J, Padberg G, et al.
Neuromuscul Disord
. 2018 Oct;
28(11):938-946.
PMID: 30342904
Overweight and obesity are common in patients with facioscapulohumeral dystrophy (FSHD) and myotonic dystrophy type 1 (DM1). Lifestyle change is often challenging for patients with neuromuscular diseases, especially to increase...
8.
Schrauwen I, Valgaeren H, Tomas-Roca L, Sommen M, Altunoglu U, Wesdorp M, et al.
Genet Med
. 2018 Oct;
21(5):1199-1208.
PMID: 30287925
Purpose: To characterize new molecular factors implicated in a hereditary congenital facial paresis (HCFP) family and otosclerosis. Methods: We performed exome sequencing in a four-generation family presenting nonprogressive HCFP and...
9.
Mul K, Voermans N, Lemmers R, Jonker M, van der Vliet P, Padberg G, et al.
Clin Genet
. 2018 Sep;
94(6):521-527.
PMID: 30211448
To determine how much of the clinical variability in facioscapulohumeral muscular dystrophy type 1 (FSHD1) can be explained by the D4Z4 repeat array size, D4Z4 methylation and familial factors, we...
10.
Wohlgemuth M, Lemmers R, Jonker M, van der Kooi E, Horlings C, van Engelen B, et al.
Neurology
. 2018 Jul;
91(5):e444-e454.
PMID: 29997197
Objective: An observational cross-sectional study was conducted in a national facioscapulohumeral muscular dystrophy (FSHD) expertise center to estimate the penetrance of FSHD1 and to evaluate phenotype-genotype correlations. Methods: Ten FSHD1...